Avantika Gupta
Angel Investor @ Newable Private Investing
London, United Kingdom
Avantika Gupta is a seed investor at Newable Private Investing in London focused on Artificial Intelligence and Biotechnology. Avantika Gupta
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Avantika Gupta invests in
Stages Avantika Gupta invests in
Countries Avantika Gupta invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 3 (33%)
- Biotechnology 2 (22%)
- SaaS 1 (11%)
- Music 1 (11%)
- Sales 1 (11%)
Stage
- Seed 3 (33%)
- Series A 3 (33%)
- Venture - Series Unknown 1 (11%)
Country
- United Kingdom 5 (56%)
- United States 2 (22%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mandolin is a digital platform designed to help artists, venues, and fans connect through live music. The platform facilitates and offers content creation, distribution, live-streaming of music shows and events and fans' insights, enabling the music community to bring live music back to the stage. | $40M / Series A / Jun 25, 2025 | ||
| Mandolin delivers precision automation tools for specialty drug processing workflows. It automates the full end-to-end lifecycle of tasks such as intake & onboarding (reading referral forms, lab reports, clinical notes), benefits verification (navigating payer portals and extracting eligibility data), patient out-of-pocket estimation, medicalpolicy review and prior authorizations, and claims status plus appeals. Mandolin uses AI agents to perform many of the manual, repetitive tasks that typically occupy back-office teams. It ensures that every action is transparent, logged, and aligned with healthcare payer requirements and regulatory standards. | $40M / Series A / Jun 25, 2025 | ||
| TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. | $5.8M / Series A / Nov 08, 2022 | ||
| TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. | Series A / Aug 01, 2022 | ||
| NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.5M / Venture - Series Unknown / Jul 16, 2021 | ||
| NuVision™ is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating ‘front of the eye’ disease and trauma. Dr Andrew Hopkinson, the Principal Research Fellow in Academic Ophthalmology, Division of Clinical Neuroscience at theUniversity of Nottingham, founded NuVision™. The business is co-owned by the founders, Dr Andrew Hopkinson (Chief Scientific Officer), Professor Harminder Dua (co-founder), the directors Mr Byran Lister (CEO) and Dr Helen Shaw (Chairman), and the University of Nottingham. | $2.2M / Venture - Series Unknown / Apr 22, 2021 | ||
| Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existingbio-design limits imposed by conventional peptide synthesis, with one universal process. | Seed / Apr 22, 2021 | ||
| Elemendar is building Artificial Intelligence that reads cyber threat reports by humans and turns them into industry-standard structured information. | Seed / Dec 05, 2020 | ||
| Kluster is at the forefront of predictive sales analytics. Harnessing the advanced modeling technology available, they give partners the tools to close more opportunities and forecast more accurately than ever before.Businesses have been tirelessly logging data on their CRMs for years. Kluster Intelligence turns this data into actionable insightsspecifically geared towards commercial gain. Intelligent reporting: comprehensive, flexible, pre-built reporting specifically for salespeople.Opportunity Management: Prioritise the right opportunities, identify those at risk, and continually monitor the top-level pipeline.Predictive Forecasting: Utilise sophisticated machine learning to produce live and accurate sales forecasts. | $1M / Seed / Apr 30, 2020 |
Co-Investors
Newable Ventures is a private investment group that connects early-stage investors with high-growth scale-up companies. They provide Private Investors, Family Offices, and Corporate Investors the opportunity to invest in potentially high-growth early-stage knowledge-intensive companies. Many of their Investors not only invest in the companies they present but also work alongside them as Lead Investors to help them unleash their potential. Having been in operation for over 30 years they have developed an extensive ecosystem of investors, co-investors, and partners who they work with to ensure they have an extensive pipeline of early-stage companies to work with. Investors are able to attend their Investor Events to meet entrepreneurs directly or invest in their Funds for a more passive approach. Typically they invest in UK-based innovative companies who qualify for investment under the Enterprise and/ or Seed Enterprise Investment Schemes.
Newable Private Investing Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexander Sleigh
Investment Director
|
|||
Anthony Clark
Director
|
|||
Hitesh Thakrar
Director
|
|||
Charles Breese
Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Avantika Gupta invest in?
Avantika Gupta invests primarily in Artificial Intelligence, Biotechnology and SaaS startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Avantika Gupta?
Public channels for Avantika Gupta include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Avantika Gupta last invest?
The most recent investment recorded for Avantika Gupta closed in Jun 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
